Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Army
US Department of Justice
Cantor Fitzgerald
Fuji
McKinsey
Johnson and Johnson
Baxter
QuintilesIMS

Generated: November 12, 2018

DrugPatentWatch Database Preview

Belmora Llc Company Profile

« Back to Dashboard

What is the competitive landscape for BELMORA LLC, and what generic and branded alternatives to BELMORA LLC drugs are available?

BELMORA LLC has four approved drugs.



Summary for Belmora Llc
US Patents:0
Tradenames:5
Ingredients:5
NDAs:4

Drugs and US Patents for Belmora Llc

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Belmora Llc LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 080504-005 Oct 19, 1983 DISCN No No ➤ Sign Up ➤ Sign Up
Belmora Llc MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 084850-002 Oct 21, 1983 DISCN No No ➤ Sign Up ➤ Sign Up
Belmora Llc LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 080504-004 Oct 19, 1983 DISCN No No ➤ Sign Up ➤ Sign Up
Belmora Llc LIDOCAINE lidocaine OINTMENT;TOPICAL 080210-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Belmora Llc MEPIVACAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 083559-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Belmora Llc LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 080504-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
Accenture
Cantor Fitzgerald
Mallinckrodt
Queensland Health
Teva
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: